06.24.2022
On Demand Webinar: High-Speed Viral Drug Product Manufacturing
Our viral drug product manufacturing facility in Rockville, MD is home to our INTEGRA® high-speed bulk filling line, with fully...
When a company develops, manufactures and delivers vaccines and therapeutics that take on the most serious global health threats, it’s not surprising to see their name in the headlines. And we are honored that for more than 20 years, Emergent has been one of those names. Included below are prominent news and feature stories that profile a range of our accomplishments through the years as well as advancements we’ve made in the technologies, processes and expertise needed to serve as a premier CDMO.
06.24.2022
Our viral drug product manufacturing facility in Rockville, MD is home to our INTEGRA® high-speed bulk filling line, with fully...
05.11.2022
Located in Thörishaus, Switzerland, just outside of Bern, our European-based site has expertise in mammalian, microbial, and...
04.14.2022
Emergent recently had the pleasure of participating in the Molecule to Market Podcast hosted by Ramen Sehgal from from ra...
03.21.2022
As a CDMO, Emergent has been working for more than two decades to develop, manufacture, and deliver protections against public...
03.14.2022
Many CDMOs specialize in certain parts of the drug development lifecycle. Meanwhile, integrated turn-key offerings that support...
03.14.2022
Emergent is pleased to announce the addition of two senior leaders to its CDMO and Quality & Compliance organizations.